Want to see HK:9686 full AI Analyst Report?
Top Page
NEUSOFT XIKANG HOLDINGS INC.
(9686)
Select Model
Select Model
Rating:44Neutral
Price Target:
HK$0.97
▲(7.78% Upside)
Action:Reiterated
Date:03/25/26
The score is held back primarily by contracting revenue, ongoing net losses, and meaningful leverage, despite improving operating cash flow. Technicals add limited support with negative MACD and the price still below longer-term moving averages. Valuation is also a drag because earnings are negative and no dividend yield is available.
Positive Factors
Improving operating cash flow
A shift to positive operating cash flow in 2024 and further improvement in 2025 indicates the business is beginning to generate internal cash to fund operations. This durable improvement reduces reliance on external financing and supports reinvestment or gradual deleveraging if sustained.
Negative Factors
Contracting revenue
Sustained top-line declines of ~6.7% and ~9.7% across 2024–2025 compress scale and reduce operating leverage. Continued revenue contraction undermines the company’s ability to cover fixed costs and invest in growth, making a durable recovery to positive operating earnings more challenging.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving operating cash flow
A shift to positive operating cash flow in 2024 and further improvement in 2025 indicates the business is beginning to generate internal cash to fund operations. This durable improvement reduces reliance on external financing and supports reinvestment or gradual deleveraging if sustained.
Read all positive factors
NEUSOFT XIKANG HOLDINGS INC. (9686) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$816.62M
Dividend YieldN/A
Average Volume (3M)60.92K
Price to Earnings (P/E)―
Beta (1Y)0.30
Revenue Growth-7.24%
EPS Growth53.79%
CountryHK
Employees855
SectorHealthcare
Sector Strength45
IndustrySoftware - Services
Share Statistics
EPS (TTM)-0.08
Shares Outstanding841,876,830
10 Day Avg. Volume65,850
30 Day Avg. Volume60,916
Financial Highlights & Ratios
PEG Ratio0.33
Price to Book (P/B)2.17
Price to Sales (P/S)1.47
P/FCF Ratio45.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NEUSOFT XIKANG HOLDINGS INC. Business Overview & Revenue Model
Company Description
Xikang Cloud Hospital Holdings Inc. specializes in constructing customized digital healthcare platforms designed for urban settings. Its business operations are structured into four main categories: Cloud Hospital Platform Services, Internet Medic...
How the Company Makes Money
null...
NEUSOFT XIKANG HOLDINGS INC. Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
40
Negative
Cash Flow
55
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 500.89M | 464.14M | 501.50M | 537.72M | 687.41M | 614.30M |
| Gross Profit | 144.25M | 126.96M | 147.50M | 164.61M | 168.45M | 170.23M |
| EBITDA | -45.88M | -23.33M | -52.06M | -75.65M | -161.41M | -214.71M |
| Net Income | -72.38M | -38.93M | -83.05M | -154.65M | -241.97M | -296.54M |
Balance Sheet | ||||||
| Total Assets | 1.11B | 1.14B | 1.26B | 1.40B | 934.45M | 946.85M |
| Cash, Cash Equivalents and Short-Term Investments | 703.42M | 760.09M | 797.70M | 822.67M | 351.76M | 364.91M |
| Total Debt | 520.84M | 518.78M | 574.47M | 603.44M | 573.44M | 456.28M |
| Total Liabilities | 785.76M | 827.90M | 892.31M | 964.28M | 1.38B | 1.21B |
| Stockholders Equity | 322.38M | 313.54M | 363.31M | 428.14M | -451.98M | -274.55M |
Cash Flow | ||||||
| Free Cash Flow | 36.20M | 14.93M | 21.56M | -24.42M | -81.17M | -101.77M |
| Operating Cash Flow | 35.91M | 20.26M | 21.56M | -20.16M | -73.83M | -83.38M |
| Investing Cash Flow | -30.55M | -153.83M | 110.45M | -146.60M | -8.45M | -5.47M |
| Financing Cash Flow | -93.62M | -67.22M | -56.56M | 504.77M | 64.62M | 64.90M |
NEUSOFT XIKANG HOLDINGS INC. Technical Analysis
Positive
0.90
Price Trends
0.96
Positive
0.92
Positive
0.93
Positive
Market Momentum
<0.01
Positive
47.64
Neutral
41.01
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:9686, the sentiment is Positive. The current price of 0.9 is below the 20-day moving average (MA) of 0.99, below the 50-day MA of 0.96, and below the 200-day MA of 0.93, indicating a neutral trend. The MACD of <0.01 indicates Positive momentum. The RSI at 47.64 is Neutral, neither overbought nor oversold. The STOCH value of 41.01 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:9686.
NEUSOFT XIKANG HOLDINGS INC. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | HK$364.43M | 11.12 | 4.28% | 7.10% | -2.78% | -24.77% | |
54 Neutral | HK$1.46B | 102.86 | 0.48% | 0.49% | -2.63% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | HK$480.01M | -1.20 | -10.69% | 1.72% | -8.94% | -140.82% | |
48 Neutral | HK$1.07B | -40.52 | -2.00% | ― | 10.88% | 90.15% | |
44 Neutral | HK$816.62M | -18.15 | -11.58% | ― | -7.24% | 53.79% |
* Healthcare Sector Average
HK:9686
NEUSOFT XIKANG HOLDINGS INC.
0.97
0.06
6.59%
HK:2138
EC Healthcare
0.41
-0.16
-28.95%
HK:2251
Beijing Airdoc Technology Co. Ltd. Class H
11.08
-1.70
-13.30%
HK:2279
Yonghe Medical Group Co., Ltd.
2.06
0.47
29.80%
HK:3886
Town Health International Medical Group Ltd.
0.22
-0.02
-8.47%
HK:0722
UMP Healthcare Holdings Limited
0.46
<0.01
1.79%
NEUSOFT XIKANG HOLDINGS INC. Corporate Events
Xikang Cloud Hospital to Deploy Idle IPO Funds into Low-Risk Cash Management
Jun 12, 2026
Xikang Cloud Hospital Holdings Inc. has resolved to continue deploying part of its idle proceeds from its HK$554.5 million global offering into low-risk, highly liquid wealth management products for cash management purposes. The board has approved...
Xikang Cloud Hospital Wins Full Shareholder Backing for AGM Resolutions and Capital Mandates
May 21, 2026
Shareholders of Xikang Cloud Hospital Holdings Inc. approved all resolutions at the annual general meeting held on 21 May 2026, including the adoption of the 2025 audited financial statements, the re-election of key board members and the re-appoin...
Xikang Cloud Hospital Sets 2026 AGM, Seeks Fresh Share Issuance Mandate
Apr 22, 2026
Xikang Cloud Hospital Holdings Inc. has called its annual general meeting for May 21, 2026, in Shenyang, where shareholders will review and adopt the audited consolidated financial statements, directors’ report and auditor’s report for...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.